Uysal-Onganer, P.; D’Alessio, S.; Mortoglou, M.; Kraev, I.; Lange, S.
Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures. Int. J. Mol. Sci. 2021, 22, 1396.
https://doi.org/10.3390/ijms22031396
AMA Style
Uysal-Onganer P, D’Alessio S, Mortoglou M, Kraev I, Lange S.
Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures. International Journal of Molecular Sciences. 2021; 22(3):1396.
https://doi.org/10.3390/ijms22031396
Chicago/Turabian Style
Uysal-Onganer, Pinar, Stefania D’Alessio, Maria Mortoglou, Igor Kraev, and Sigrun Lange.
2021. "Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures" International Journal of Molecular Sciences 22, no. 3: 1396.
https://doi.org/10.3390/ijms22031396
APA Style
Uysal-Onganer, P., D’Alessio, S., Mortoglou, M., Kraev, I., & Lange, S.
(2021). Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures. International Journal of Molecular Sciences, 22(3), 1396.
https://doi.org/10.3390/ijms22031396
